On July 11, 2022, the United States District Court for the District of Kansas approved a $264 million settlement against Mylan and certain of its subsidiaries in the case In Re EpiPen (Epinephrine ...
A lawsuit against Colorado’s EpiPen access law can move to trial. The law went into effect last January, making epinephrine auto-injectors for people with severe allergies much cheaper. It brought the ...
Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment devices ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback